Skip to main content
$340.46 -$1.64 (-0.5%)

03:59 PM EST on 01/30/23

Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 3 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Current Price $340.46 Mkt Cap $325.1B
Open $344.33 P/E Ratio 51.18
Prev. Close $342.10 Div. (Yield) $4.52 (1.3%)
Daily Range $339.46 - $347.80 Volume 2,089,178
52-Wk Range $231.87 - $384.44 Avg. Daily Vol. 2,530,388

Caps

How do you think NYSE:LLY will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,246 Outperform
102 Underperform
 

All-Star Players

316 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:LLY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

advcards (< 20)
Submitted September 13, 2022

Weight Loss Drug

einzling44 (< 20)
Submitted May 15, 2012

cap spending ahead

Recent Community Commentary

Read the most recent pitches from players about LLY.

Recs

0
Member Avatar NHWeston102 (65.55) Submitted: 11/17/2022 3:06:06 PM : Outperform Start Price: $360.61 NYSE:LLY Score: -8.02

This pharma company doesn't have a pipeline; they have a fire hose! Strong entries in weight control, immunology, oncology and a brand new diabetes treatment. Lilly also has an Alzhimers drug with enormous potential in a country where millions of us are outliving our cognitive functions.

Recs

1
Member Avatar advcards (< 20) Submitted: 9/13/2022 11:51:35 AM : Outperform Start Price: $308.79 NYSE:LLY Score: +9.24

Weight Loss Drug

Recs

1
Member Avatar mrbill6 (59.69) Submitted: 6/16/2022 2:42:46 PM : Outperform Start Price: $284.36 NYSE:LLY Score: +9.61

A stock that will beat the doomsday crash

Leaderboard

Find the members with the highest scoring picks in LLY.

Score Leader

thomasgb

thomasgb (38.12) Score: +1,294.86

The Score Leader is the player with the highest score across all their picks in LLY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
thomasgb 38.12 3/4/2009 Outperform 3Y $18.20 +1,767.39% +472.53% +1,294.86 0 Comment
MarketPwnage 79.10 3/9/2009 Outperform NS $18.04 +1,783.60% +500.68% +1,282.92 0 Comment
tektan 90.09 3/9/2009 Outperform 5Y $18.04 +1,783.60% +500.68% +1,282.92 0 Comment
MCMInvest 77.41 3/9/2009 Outperform NS $18.04 +1,783.60% +500.68% +1,282.92 0 Comment
harryhotspur1403 68.61 10/10/2008 10/14/2011 Outperform 1Y $19.42 +1,649.90% +374.12% +1,275.78 0 Comment
LordCoolio 63.76 3/2/2009 Outperform 3M $18.57 +1,729.46% +463.05% +1,266.41 0 Comment
fredericch 98.32 3/2/2009 Outperform NS $18.57 +1,729.46% +463.05% +1,266.41 0 Comment
eyeseeu2 98.63 11/21/2008 Outperform NS $18.95 +1,692.78% +431.46% +1,261.32 0 Comment
srdreyer 75.36 10/28/2008 Outperform 1Y $19.54 +1,638.57% +377.90% +1,260.67 0 Comment
juliehowe 68.10 10/28/2008 Outperform 1Y $19.67 +1,627.34% +368.76% +1,258.59 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for LLY.